Zentalis Pharmaceuticals Correlations

ZNTL Stock

USD 2.15 0.03 1.42%

The current 90-days correlation between Zentalis Pharmaceuticals and Olema Pharmaceuticals is 0.23 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zentalis Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zentalis Pharmaceuticals Llc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Zentalis Pharmaceuticals Correlation With Market

Modest diversification

The correlation between Zentalis Pharmaceuticals Llc and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis Pharmaceuticals Llc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving together with Zentalis Stock

0.83	INZY	Inozyme Pharma	Pair Corr
0.85	ABOS	Acumen Pharmaceuticals	Pair Corr
0.87	ADTX	Aditxt Inc	Pair Corr
0.67	STRO	Sutro Biopharma	Pair Corr
0.81	TCRX	Tscan Therapeutics	Pair Corr
0.85	TERN	Terns Pharmaceuticals	Pair Corr
0.88	CRNX	Crinetics Pharmaceuticals Earnings Call Today	Pair Corr
0.78	CTMX	CytomX Therapeutics	Pair Corr
0.67	DAWN	Day One Biopharmaceu	Pair Corr

Moving against Zentalis Stock

0.82	OPT	Opthea Earnings Call Today	Pair Corr
0.74	LTRN	Lantern Pharma	Pair Corr
0.65	GANX	Gain Therapeutics	Pair Corr
0.62	PHGE	Biomx Inc	Pair Corr
0.57	CUE	Cue Biopharma	Pair Corr
0.56	A	Agilent Technologies Earnings Call Today	Pair Corr
0.49	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.41	FENC	Fennec Pharmaceuticals	Pair Corr
0.62	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.55	CPRX	Catalyst Pharmaceuticals Earnings Call Today	Pair Corr
0.54	CGTX	Cognition Therapeutics	Pair Corr
0.92	OBI	Ondine Biomedical	Pair Corr
0.74	SSNLF	Samsung Electronics	Pair Corr
0.71	GPI	Group 1 Automotive	Pair Corr
0.67	EC	Ecopetrol SA ADR Earnings Call Today	Pair Corr

Related Correlations Analysis

	SANA	OLMA	CGEM	LIFE	GRCL	THRX	GLUE	DSGN	ERAS	DAWN
SANA		-0.19	-0.51	0.0	0.0	0.0	-0.38	-0.69	-0.53	-0.33	SANA
OLMA	-0.19		0.78	0.0	0.0	0.0	0.9	0.54	0.75	0.89	OLMA
CGEM	-0.51	0.78		0.0	0.0	0.0	0.77	0.79	0.94	0.79	CGEM
LIFE	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	LIFE
GRCL	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	GRCL
THRX	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	THRX
GLUE	-0.38	0.9	0.77	0.0	0.0	0.0		0.59	0.76	0.83	GLUE
DSGN	-0.69	0.54	0.79	0.0	0.0	0.0	0.59		0.85	0.62	DSGN
ERAS	-0.53	0.75	0.94	0.0	0.0	0.0	0.76	0.85		0.73	ERAS
DAWN	-0.33	0.89	0.79	0.0	0.0	0.0	0.83	0.62	0.73		DAWN
	SANA	OLMA	CGEM	LIFE	GRCL	THRX	GLUE	DSGN	ERAS	DAWN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ERAS	+ 0.94	CGEM
GLUE	+ 0.9	OLMA
DAWN	+ 0.89	OLMA
ERAS	+ 0.85	DSGN
DAWN	+ 0.83	GLUE
DSGN	+ 0.79	CGEM

High negative correlations

DSGN	- 0.69	SANA
ERAS	- 0.53	SANA
CGEM	- 0.51	SANA
GLUE	- 0.38	SANA
DAWN	- 0.33	SANA
OLMA	- 0.19	SANA

Risk-Adjusted Indicators

There is a big difference between Zentalis Stock performing well and Zentalis Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zentalis Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SANA	8.05	1.35	0.19	0.49	6.39	(11.15)	12.46	(11.88)	176.41
OLMA	4.44	(0.79)	0.00	(0.25)	0.00	0.00	7.46	(9.67)	31.66
CGEM	2.48	(0.65)	0.00	(1.68)	0.00	0.00	4.98	(6.27)	15.27
LIFE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GRCL	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
THRX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GLUE	3.77	(0.30)	0.00	(0.21)	0.00	0.00	8.40	(8.27)	23.57
DSGN	4.16	(0.13)	0.00	0.51	0.00	0.00	8.72	(11.01)	26.51
ERAS	3.24	(0.93)	0.00	(0.95)	0.00	0.00	4.48	(8.74)	26.76
DAWN	1.83	(0.13)	0.00	(0.30)	0.00	0.00	3.92	(3.28)	10.17

Zentalis Pharmaceuticals Corporate Management

Vincent Vultaggio	VP Officer	Profile
Kevin Bunker	CoFounder Officer	Profile
Carrie MD	Chief Officer	Profile
Adrian MD	Executive Development	Profile
Mark Lackner	Chief Strategy	Profile
Ingmar MD	Chief Officer	Profile
Kimberly Freeman	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC